These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9625155)

  • 1. Helicobacter pylori urease inhibition and ammonia levels in cirrhotic patients.
    Zullo A; Rinaldi V; Folino S; Diana F; Attili AF
    Am J Gastroenterol; 1998 May; 93(5):851-2. PubMed ID: 9625155
    [No Abstract]   [Full Text] [Related]  

  • 2. Helicobacter pylori and plasma ammonia levels in cirrhotics: role of urease inhibition by acetohydroxamic acid.
    Zullo A; Rinaldi V; Hassan C; Folino S; Winn S; Pinto G; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):405-9. PubMed ID: 9789138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Helicobacter pylori-induced gastritis by urease inhibitors in Mongolian gerbils.
    Shibata H; Ohta T; Iimuro M; Kitamura T; Yokokura T; Wakabayashi K
    Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():154-8. PubMed ID: 11890100
    [No Abstract]   [Full Text] [Related]  

  • 4. Supramolecular assembly and acid resistance of Helicobacter pylori urease.
    Ha NC; Oh ST; Sung JY; Cha KA; Lee MH; Oh BH
    Nat Struct Biol; 2001 Jun; 8(6):505-9. PubMed ID: 11373617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in serum ammonia concentration in cirrhotic patients with Helicobacter pylori infection.
    Si J; Cao Q; Gao M; Fang L; Qian G; Wang Y
    Chin Med J (Engl); 2000 Dec; 113(12):1080-1. PubMed ID: 11776140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.
    Xiao ZP; Peng ZY; Dong JJ; Deng RC; Wang XD; Ouyang H; Yang P; He J; Wang YF; Zhu M; Peng XC; Peng WX; Zhu HL
    Eur J Med Chem; 2013 Oct; 68():212-21. PubMed ID: 23974021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients.
    Zullo A; Rinaldi V; Meddi P; Hassan C; Winn S; Attili AF
    Am J Gastroenterol; 1999 Aug; 94(8):2214-8. PubMed ID: 10445552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ammonia production in the human colon. Effects of cleansing, neomycin and acetohydroxamic acid.
    Wolpert E; Phillips SF; Summerskill WH
    N Engl J Med; 1970 Jul; 283(4):159-64. PubMed ID: 5424005
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of urease activity but not growth of Helicobacter pylori by acetohydroxamic acid.
    Goldie J; Veldhuyzen van Zanten SJ; Jalali S; Richardson H; Hunt RH
    J Clin Pathol; 1991 Aug; 44(8):695-7. PubMed ID: 1890207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperammonaemia and Helicobacter pylori.
    Ito S; Miyaji H; Azuma T; Li Y; Ito Y; Kato T; Kohli Y; Kuriyama M
    Lancet; 1995 Jul; 346(8967):124-5. PubMed ID: 7603197
    [No Abstract]   [Full Text] [Related]  

  • 11. Marked reduction of Helicobacter pylori-induced gastritis by urease inhibitors, acetohydroxamic acid and flurofamide, in Mongolian gerbils.
    Ohta T; Shibata H; Kawamori T; Iimuro M; Sugimura T; Wakabayashi K
    Biochem Biophys Res Commun; 2001 Jul; 285(3):728-33. PubMed ID: 11453654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.
    Ni WW; Liu Q; Ren SZ; Li WY; Yi LL; Jing H; Sheng LX; Wan Q; Zhong PF; Fang HL; Ouyang H; Xiao ZP; Zhu HL
    Bioorg Med Chem; 2018 Aug; 26(14):4145-4152. PubMed ID: 29983280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of urease inhibition in hyperammonemia: clinical and experimental studies with acetohydroxamic acid.
    Summerskill WH; Thorsell F; Feinberg JH; Aldrete JS
    Gastroenterology; 1968 Jan; 54(1):20-6. PubMed ID: 5635434
    [No Abstract]   [Full Text] [Related]  

  • 14. Amines and oximes derived from deoxybenzoins as Helicobacter pylori urease inhibitors.
    Li HQ; Xiao ZP; Yin-Luo ; Yan T; Lv PC; Zhu HL
    Eur J Med Chem; 2009 May; 44(5):2246-51. PubMed ID: 18625539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Helicobacter pylori urease activity by hydroxamic acid derivatives.
    Odake S; Morikawa T; Tsuchiya M; Imamura L; Kobashi K
    Biol Pharm Bull; 1994 Oct; 17(10):1329-32. PubMed ID: 7874052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
    Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
    Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori springs another surprise.
    Dunn BE; Grütter MG
    Nat Struct Biol; 2001 Jun; 8(6):480-2. PubMed ID: 11373609
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening system for urease inhibitors using 13C-NMR.
    Chiyoda T; Iida K; Takatori K; Kajiwara M
    Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):718-20. PubMed ID: 9579048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori infection in dyspeptic cirrhotic patients.
    Zullo A; Rinaldi V; Meddi P; Folino S; Lauria V; Diana F; Winn S; Attili AF
    Hepatogastroenterology; 1999; 46(25):395-400. PubMed ID: 10228829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico study of the active site of Helicobacter pylori urease and its inhibition by hydroxamic acids.
    Arora R; Issar U; Kakkar R
    J Mol Graph Model; 2018 Aug; 83():64-73. PubMed ID: 29775804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.